UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report

European journal of clinical pharmacology, 2022-05, Vol.78 (5), p.891-893

2022

Link zum Volltext

Verfügbarkeit prüfen

DNA extraction from fresh and frozen plasma: an alternative for real-time PCR genotyping in pharmacogenetics

Molecular biology reports, 2020-08, Vol.47 (8), p.6451-6455

2020

Link zum Volltext

Verfügbarkeit prüfen

ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment

The pharmacogenomics journal, 2021-10, Vol.21 (5), p.586-593

2021

Link zum Volltext

Verfügbarkeit prüfen

In linezolid underexposure, pharmacogenetics matters: The role of CYP3A5

Biomedicine & pharmacotherapy, 2021-07, Vol.139, p.111631-111631, Article 111631

2021

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges

Pharmaceutics, 2023-06, Vol.15 (7), p.1834

2023

Link zum Volltext

Verfügbarkeit prüfen

Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?

The pharmacogenomics journal, 2019-10, Vol.19 (5), p.465-472

2019

Link zum Volltext

Verfügbarkeit prüfen

Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients

The pharmacogenomics journal, 2021-08, Vol.21 (4), p.491-497

2021

Link zum Volltext

Verfügbarkeit prüfen

Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy

BMC infectious diseases, 2018-11, Vol.18 (1), p.556-556, Article 556

2018

Link zum Volltext

Verfügbarkeit prüfen

Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation

BMC biology, 2009-07, Vol.7 (1), p.41-41, Article 41

2009

Link zum Volltext

Verfügbarkeit prüfen

Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns

PloS one, 2011-06, Vol.6 (6), p.e20966-e20966

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical and genetic determinants of nevirapine plasma trough concentration

SAGE open medicine, 2018-06, Vol.6, p.2050312118780861-2050312118780861

2018

Link zum Volltext

Verfügbarkeit prüfen

Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure

Frontiers in pediatrics, 2019-07, Vol.7, p.309-309

2019

Link zum Volltext

Verfügbarkeit prüfen

Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase

International Journal of Molecular Sciences, 2015-04, Vol.16 (4), p.8884-8895

2015

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience

The world journal of biological psychiatry, 2021-01, Vol.22 (1), p.34-45

2021

Link zum Volltext

Verfügbarkeit prüfen

Different effects of glucocorticoids on darunavir plasma concentrations

European journal of clinical pharmacology, 2019-05, Vol.75 (5), p.733-735

2019

Link zum Volltext

Verfügbarkeit prüfen

Response to: "Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?" [Response to Letter]

Pharmacogenomics and personalized medicine, 2024, Vol.17, p.51-52

2024

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults

Expert review of neurotherapeutics, 2024-04, Vol.24 (4), p.325-332

2024

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping

Pharmacogenomics and personalized medicine, 2023-01, Vol.16, p.739-746

2023

Link zum Volltext

Verfügbarkeit prüfen

Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication

Digestive and liver disease, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study

The pharmacogenomics journal, 2023-09, Vol.23 (5), p.112-118

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetic variants in bipolar disorder with elevated treatment resistance and intolerance: Towards a personalized pattern of care

Bipolar disorders, 2019-05, Vol.21 (3), p.288-291

2019

Link zum Volltext

Verfügbarkeit prüfen

Correction to: One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study

The pharmacogenomics journal, 2023-09, Vol.23 (5), p.140-140

2023

Link zum Volltext

Verfügbarkeit prüfen

Case of Suboptimal Linezolid Exposure: Is There a Role for Pharmacogenetics?

Therapeutic drug monitoring, 2020-04, Vol.42 (2), p.347

2020

Link zum Volltext

Verfügbarkeit prüfen

DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan

British journal of clinical pharmacology, 2015-09, Vol.80 (3), p.581-588

2015

Link zum Volltext

Verfügbarkeit prüfen

HLA-B57

Pharmacogenetics and genomics, 2017-02, Vol.27 (2), p.81-82

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(44)
Berichte
(3)

Sprache

Englisch
(47)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Fast clearance of anti-TNFα agents unrelated to antidrug antibodies: a case report

DNA extraction from fresh and frozen plasma: an alternative for real-time PCR genotyping in pharmacogenetics

ABCC4 single-nucleotide polymorphisms as markers of tenofovir disoproxil fumarate-induced kidney impairment

In linezolid underexposure, pharmacogenetics matters: The role of CYP3A5

Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges

Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?

Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients

Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy

Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation

Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns

Clinical and genetic determinants of nevirapine plasma trough concentration

Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure

Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase

Therapeutic drug monitoring and pharmacogenetics of antipsychotics and antidepressants in real life settings: A 5-year single centre experience

Different effects of glucocorticoids on darunavir plasma concentrations

Response to: "Challenges in DPYD Test Implementation in Patients Treated with Fluoropyirimidines, is DPYD Genotype Arriving on Time?" [Response to Letter]

Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults

Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping

Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication

One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study

Pharmacogenetic variants in bipolar disorder with elevated treatment resistance and intolerance: Towards a personalized pattern of care

Correction to: One year of experience with combined pharmacokinetic/pharmacogenetic monitoring of anti-TNF alpha agents: a retrospective study

Case of Suboptimal Linezolid Exposure: Is There a Role for Pharmacogenetics?

DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan

HLA-B57

Suchergebnisse filtern